Early detection of colonic polyps and their prompt removal is a fundamental goal of colorectal cancer screening and prevention. Results of a new multicentre study demonstrate sensitivity for the ScheBo M2-PK Quick test of 92.8% for bowel cancer and 69.4% for polyps. The ScheBo M2-PK Quick test detected twice as many bowel cancer cases and nearly six times the number of polyps compared with an immunological faecal occult blood test (FIT) also included in the study.
UK NEQAS IMPROVES PATIENT CARE
We aim to improve patient care through monitoring the quality of tests and their reporting, in an independent manner and on a not-for-profit basis.
We are here to help ensure optimal quality in testing for the benefit of patients.
We believe that the result of tests should be:
RAF Museum, Hendon, London NW9 5LL
15 May, 2025
Royal College Of Physicians Of Edinburgh
15 May, 2025
Jubilee Hotel and Conference Centre, Nottingham, UK
15 May, 2025
Online
21 May 2025
Online
9 June 2025
